Labcorp Holdings [LH] vs Thermo Fisher [TMO] Detailed Stock Comparison
Labcorp Holdings
NYSE
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Labcorp Holdings wins in 8 metrics, Thermo Fisher wins in 12 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Labcorp Holdings | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.67 | 28.95 | Thermo Fisher |
| Price-to-Book Ratio | 2.72 | 3.74 | Labcorp Holdings |
| Debt-to-Equity Ratio | 77.78 | 69.62 | Thermo Fisher |
| PEG Ratio | 1.83 | 5.10 | Labcorp Holdings |
| EV/EBITDA | 15.96 | 19.56 | Labcorp Holdings |
| Profit Margin (TTM) | 5.66% | 15.24% | Thermo Fisher |
| Operating Margin (TTM) | 11.30% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | 11.30% | 17.84% | Thermo Fisher |
| Return on Equity | 9.26% | 13.42% | Thermo Fisher |
| Return on Assets (TTM) | 4.44% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $1.10B | $7.27B | Thermo Fisher |
| Dividend Yield | 0.83% | 0.31% | Labcorp Holdings |
| 1-Year Return | 20.48% | -17.51% | Labcorp Holdings |
| Price-to-Sales Ratio (TTM) | 1.71 | 4.37 | Labcorp Holdings |
| Enterprise Value | $29.09B | $211.60B | Thermo Fisher |
| EV/Revenue Ratio | 2.16 | 4.90 | Labcorp Holdings |
| Gross Profit Margin (TTM) | 29.66% | 40.61% | Thermo Fisher |
| Revenue per Share (TTM) | $161 | $114 | Labcorp Holdings |
| Earnings per Share (Diluted) | $9.07 | $17.27 | Thermo Fisher |
| Beta (Stock Volatility) | 0.76 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Labcorp Holdings vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Labcorp Holdings | -0.74% | 2.88% | 10.36% | 15.00% | 10.64% | 21.91% |
| Thermo Fisher | -1.85% | 2.25% | 16.92% | 24.85% | -6.64% | -4.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Labcorp Holdings | 20.48% | 41.30% | 82.52% | 170.71% | 330.49% | 559.82% |
| Thermo Fisher | -17.51% | -11.30% | 17.79% | 295.19% | 1,057.92% | 1,679.96% |
Performance & Financial Health Analysis: Labcorp Holdings vs Thermo Fisher
| Metric | LH | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $23.12B | $188.80B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 517,640 | 2,025,021 |
| 90 Day Avg. Volume | 710,647 | 2,799,344 |
| Last Close | $276.11 | $490.75 |
| 52 Week Range | $209.38 - $283.47 | $385.46 - $627.88 |
| % from 52W High | -2.60% | -21.84% |
| All-Time High | $283.47 (Jul 24, 2025) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -2.60% | -27.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.03% |
| Quarterly Earnings Growth | 0.16% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.15% |
| Operating Margin (TTM) | 0.11% | 0.18% |
| Return on Equity (TTM) | 0.09% | 0.13% |
| Debt to Equity (MRQ) | 77.78 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $102.20 | $133.77 |
| Cash per Share (MRQ) | $7.79 | $16.92 |
| Operating Cash Flow (TTM) | $1.69B | $7.58B |
| Levered Free Cash Flow (TTM) | $1.03B | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.83% | 0.31% |
| Last 12-Month Dividend | $2.16 | $1.21 |
Valuation & Enterprise Metrics Analysis: Labcorp Holdings vs Thermo Fisher
| Metric | LH | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.67 | 28.95 |
| Forward P/E | 17.36 | 21.29 |
| PEG Ratio | 1.83 | 5.10 |
| Price to Sales (TTM) | 1.71 | 4.37 |
| Price to Book (MRQ) | 2.72 | 3.74 |
| Market Capitalization | ||
| Market Capitalization | $23.12B | $188.80B |
| Enterprise Value | $29.09B | $211.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.16 | 4.90 |
| Enterprise to EBITDA | 15.96 | 19.56 |
| Risk & Other Metrics | ||
| Beta | 0.76 | 0.75 |
| Book Value per Share (MRQ) | $102.20 | $133.77 |
Financial Statements Comparison: Labcorp Holdings vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LH | TMO |
|---|---|---|
| Revenue/Sales | $3.35B | $10.36B |
| Cost of Goods Sold | $2.40B | $6.13B |
| Gross Profit | $948.00M | $4.24B |
| Research & Development | N/A | $342.00M |
| Operating Income (EBIT) | $332.40M | $1.82B |
| EBITDA | $497.90M | $2.73B |
| Pre-Tax Income | $275.20M | $1.62B |
| Income Tax | $62.20M | $95.00M |
| Net Income (Profit) | $213.00M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LH | TMO |
|---|---|---|
| Cash & Equivalents | $369.40M | $4.13B |
| Total Current Assets | $3.79B | $23.38B |
| Total Current Liabilities | $2.06B | $13.17B |
| Long-Term Debt | $6.33B | $31.37B |
| Total Shareholders Equity | $8.32B | $49.49B |
| Retained Earnings | $8.46B | $54.45B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LH | TMO |
|---|---|---|
| Operating Cash Flow | $148.20M | $2.15B |
| Capital Expenditures | N/A | $-350.00M |
| Free Cash Flow | $-107.50M | $361.00M |
| Debt Repayment | $-1.06B | $-838.00M |
| Common Stock Repurchase | N/A | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | LH | TMO |
|---|---|---|
| Shares Short | 2.75M | 3.71M |
| Short Ratio | 3.24 | 1.14 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 517,640 | 2,025,021 |
| Average Daily Volume (90 Day) | 710,647 | 2,799,344 |
| Shares Outstanding | 83.40M | 380.77M |
| Float Shares | 82.66M | 376.76M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.00% | 0.92% |
Dividend Analysis & Yield Comparison: Labcorp Holdings vs Thermo Fisher
| Metric | LH | TMO |
|---|---|---|
| Last 12-Month Dividend | $2.16 | $1.21 |
| Last 12-Month Dividend Yield | 0.83% | 0.31% |
| 3-Year Avg Annual Dividend | $2.75 | $1.33 |
| 3-Year Avg Dividend Yield | 0.32% | 0.07% |
| 3-Year Total Dividends | $8.24 | $3.99 |
| Ex-Dividend Date | Feb 27, 2025 | Mar 14, 2025 |